BioCentury
ARTICLE | Clinical News

Gd-Tex: To begin patient enrollment in January for a Phase I trial

January 3, 1995 8:00 AM UTC

Pharmacyclics Inc., Sunnyvale, Calif. Product: Gd-Tex (gadolinium-texaphyrin), expanded porphyrin compound Use: Radiosensitizer in radiation therapy for cancers, and a contrast agent in magnetic res...